The New York TimesThe New York Times

Cancer Drug Greatly Reduces Deaths in Hospitalized COVID Patients

By Carl Zimmer

06 Jul 2022 · 3 min read

Editor's Note

This piece from The New York Times reports on a recent study which uncovered a cancer treatment which can be used for treating serious Covid. Read more, here.

An experimental drug initially developed to fight cancer cut the risk of death for people hospitalized with COVID by half, according to a study published Wednesday.

The drug, sabizabulin, seemed to be more effective than others that have been authorized for severely ill COVID patients. Veru, the company in Miami that developed the drug, has applied to the Food and Drug Administration for an emergency authorization of its use. That would potentially add a new weapon to the modest arsenal available to hospitalized patients, experts said.

Sign in to informed

  • Curated articles from premium publishers, ad-free
  • Concise Daily Briefs with quick-read summaries
  • Read, listen, save for later, or enjoy offline
  • Enjoy personalized content